chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 47.0
Sex: F
Vaccine: HEP
Symptoms: Migraine, Visual impairment
Clinical narrative: This case was reported by a consumer and described the occurrence of lightheadedness in a 47-year-old female subject who was vaccinated with ENGERIX B (GlaxoSmithKline). A physician or other health care professional has not verified this report. On 12 August 2009 at 12:30 the subject received 1st dose of ENGERIX B (left arm). On 13 August 2009, 1 day after vaccination with ENGERIX B, the subject experienced lightheadedness and dizziness. On 20 August 2009, 8 days after vaccination with ENGERIX B, the subject experienced disorientation and blood pressure dropped. On an unspecified date(s), an unspecified time after vaccination with ENGERIX B, the subject experienced chest pain, intermittent and inability to concentrate. At the time of reporting, lightheadedness, dizziness, disorientation, blood pressure dropped and inability to concentrate were unresolved. The outcome of chest pain, intermittent was unspecified. On 13 August 2009, the subject experienced "vaccine lightheadedness and dizziness". On 20 August 2009, she experienced disorientation and blood pressure dropped into the 80's. She also experienced intermittent chest pain. The disorientation and drop in blood pressure comes and goes in waves. She can be fine for a few hours and then both issues return. She visited her physician the afternoon of 20 August 2009. She has been drinking more water to get her blood pressure back up and making sure she has iodine. She has not been able to get her blood pressure above the mid-90's. The night of 23 August 2009, she became disoriented again. The morning of 24 August 2009, her blood pressure was in the mid-80's. She can not concentrate. Follow-up information was received on 24 September 2009. The subject reported that the symptoms she previously reported (lightheadedness, dizziness, disorientation, blood pressure dropped) are all worse since last reported on 24 August 2009. The subject reported that this weekend (19 September 2009) she began to experience migraine headaches and visual problems (vision will go in and out of focus and not related to the migraine). The subject planned to continue follow-up with her physician and be evaluated by a neurologist on an unknown date. The subject reported that she has been unable to work because of her condition.
Age: 57.0
Sex: M
Vaccine: HEP
Symptoms: Vision blurred
Clinical narrative: This case was reported by a physician and described the occurrence of blurred vision in an adult male subject who was vaccinated with ENGERIX B. On unspecified dates, the subject received the 1st and 2nd dose of ENGERIX B (unknown). One day after vaccination with ENGERIX B, the subject experienced blurred vision. The physician reported seeing the subject who received two doses of ENGERIX B and experienced blurred vision the following day after receiving ENGERIX B both times. The physician was no sure when the doses were given but stated the 3rd dose was due 17 November 2008 and they were following the 0, 1, 6 month dosing schedule. The immunization series was discontinued. At the time of reporting the outcome of the events were unspecified.
Sex: M
Vaccine: HEP
Symptoms: Hepatitis B core antigen positive, Hepatitis B surface antigen positive, Liver function test normal
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of hepatitis b surface antigen positive in an adult male subject who was vaccinated with hepatitis B vaccine recombinant (Engerix B, GlaxoSmithKline) for prophylaxis. On 28 September 2008, the subject received 1st dose of Engerix B (unknown). On 2 October 2008, 4 days after vaccination with Engerix B, the subject experienced hepatitis b surface antigen positive, antigenemia and hepatitis b core antigen positive. An adult subject raised in the Philippines was seen in the United stated by a healthcare professional in a missionary organization. The subject may have a possible history of Hepatitis b infection due to positive hepatitis b virus core antibodies. The subject received an Engerix B vaccination on 28 September 2008 and a hepatitis panel on 02 October 2008. The subject tested positive for hepatitis b surface antigen also possible due to vaccination. Subjects' liver function testes were normal. The healthcare professional plans to repeat the hepatitis panel in two months to determine if the antigenemia is related to the vaccine or to an infection. No other adverse events reported. At the time of reporting the events were unresolved. The healthcare professional considered the events were possibly related to vaccination with Engerix B.
Sex: U
Vaccine: HEP
Symptoms: No therapeutic response, Therapeutic response decreased
Clinical narrative: This case was reported by a physician via sales representative and described the occurrence of not responding to therapy in a subject of unspecified age and gender who was vaccinated with Hepatitis B vaccine (manufacturer unspecified). On an unspecified date, the subject received unspecified dose of Hepatitis B vaccine (unknown). At an unspecified time after vaccination with Hepatitis B vaccine, the subject experienced decreased therapeutic response. A physician had inquired via sales representative, whether a subject needed to complete another ENGERIX series or just a booster; if a subject had completed a Hepatitis B vaccine series, but serum titers were drawn, did not show complete immunity. No other information was provided.
Age: 1.48
Sex: F
Vaccine: MMR
Symptoms: Rash erythematous, Rash generalised, Rash macular, Vomiting
Clinical narrative: Pt vomited after dinner at 6PM. Red blotchy rash all over body, no fever. Pt seemed fine next AM, no rash, acting fine, eating & drinking fine. At 11AM dad noticed rash on chest, no fever, rash different from previous night, not blotchy.
Age: 32.0
Sex: M
Vaccine: ANTH, HEP
Symptoms: Chills, Fatigue, Night sweats, Pain
Clinical narrative: Received injection ^ Feb 2009 (AM).  Between 6 Feb and 9 Feb when pt was seen he complained of severe body aches, fatigue, chills and night sweats.  Self treated with Motrin.  After visit, pt was instructed to continue Motrin.
Age: 24.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL
Symptoms: Back pain, Dyspnoea, Dyspnoea exertional, Electrocardiogram abnormal, Pericarditis
Clinical narrative: Mild pericarditis treated with NSAIDs.  Patient is currently located and was vaccinated.  BP 133/85, HR 63, RR 12, temp 98.2, O2 99% on room air.  Patient c/o back pain and shortness of breath when lying down and dyspnea on exertion.
Age: 24.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL
Symptoms: Troponin
Clinical narrative: Mild pericarditis treated with NSAIDs.  Patient is currently located and was vaccinated.  BP 133/85, HR 63, RR 12, temp 98.2, O2 99% on room air.  Patient c/o back pain and shortness of breath when lying down and dyspnea on exertion.
Age: 24.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL
Symptoms: Echocardiogram abnormal, Electrocardiogram abnormal, Pericardial disease, Troponin I
Clinical narrative: Mild pericarditis treated with NSAIDs.  Patient is currently located and was vaccinated.  BP 133/85, HR 63, RR 12, temp 98.2, O2 99% on room air.  Patient c/o back pain and shortness of breath when lying down and dyspnea on exertion.
Age: 75.0
Sex: F
Vaccine: FLU(H1N1), FLU(H1N1)
Symptoms: Guillain-Barre syndrome, Nerve conduction studies normal, Nuclear magnetic resonance imaging abnormal, Paraesthesia
Clinical narrative: CLIENT REPORTED NUMBNESS IN THE LOWER EXTREMITES BILATERALLY WHICH HAS LASTED FOR ABOUT A MONTH. SHE HAS HAD MRI X 2.
Age: 75.0
Sex: F
Vaccine: FLU(H1N1), FLU(H1N1)
Symptoms: Hypoaesthesia, Nuclear magnetic resonance imaging
Clinical narrative: CLIENT REPORTED NUMBNESS IN THE LOWER EXTREMITES BILATERALLY WHICH HAS LASTED FOR ABOUT A MONTH. SHE HAS HAD MRI X 2.
Age: 0.21
Sex: F
Vaccine: RV5, RV5
Symptoms: Dysphonia
Clinical narrative: Mom states after receiving Rotateq vaccine
Age: 0.21
Sex: F
Vaccine: RV5, RV5
Symptoms: Unevaluable event
Clinical narrative: Mom states after receiving Rotateq vaccine
Age: 0.53
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, RV1, HIBV, PNC, RV5, HIBV, PNC, RV1, DTAPHEPBIP, HIBV, PNC, RV1
Symptoms: Cyanosis, Hypotonia, Loss of consciousness, Pallor
Clinical narrative: Initial report was received on 19 January 2010 from a health care professional. A six-month-old female patient had received a third dose intramuscular left thigh injection of ACT-HIB, lot number UF672AA (Sanofi Pasteur SA lot number D0551-1), and an intramuscular left thigh injection of PREVNAR (manufacturer Wyeth, lot number D81705) and an oral dose of ROTATEQ (Manufacturer GlaxoSmithKline, lot number A41FA733A) on 18 January 2010 and immediately after receiving these vaccines, the patient's eyes rolled back, she became limp, pale, slightly cyanotic around the mouth, and she stopped crying for approximately 30 seconds to one minute. The patient then began to cry again and was monitored for 30 minutes afterwards. At that time, the patient recovered and was felt to be "ok" and she was then administered a dose of PEDIARIX (lot number AC21B209DA, manufacturer, route and site not reported). According to the reporter, the patient had no concurrent illness, no past medical history, and she had not been taking any concomitant medications. The patient had not experienced any adverse events following prior vaccinations. No additional information was provided at the time of the report. Documents held by sender: None.
Age: 0.53
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, RV1, HIBV, PNC, RV5, HIBV, PNC, RV1, DTAPHEPBIP, HIBV, PNC, RV1
Symptoms: Crying, Cyanosis, Gaze palsy, Hypotonia, Immediate post-injection reaction
Clinical narrative: Initial report was received on 19 January 2010 from a health care professional. A six-month-old female patient had received a third dose intramuscular left thigh injection of ACT-HIB, lot number UF672AA (Sanofi Pasteur SA lot number D0551-1), and an intramuscular left thigh injection of PREVNAR (manufacturer Wyeth, lot number D81705) and an oral dose of ROTATEQ (Manufacturer GlaxoSmithKline, lot number A41FA733A) on 18 January 2010 and immediately after receiving these vaccines, the patient's eyes rolled back, she became limp, pale, slightly cyanotic around the mouth, and she stopped crying for approximately 30 seconds to one minute. The patient then began to cry again and was monitored for 30 minutes afterwards. At that time, the patient recovered and was felt to be "ok" and she was then administered a dose of PEDIARIX (lot number AC21B209DA, manufacturer, route and site not reported). According to the reporter, the patient had no concurrent illness, no past medical history, and she had not been taking any concomitant medications. The patient had not experienced any adverse events following prior vaccinations. No additional information was provided at the time of the report. Documents held by sender: None.
Age: 0.53
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, RV1, HIBV, PNC, RV5, HIBV, PNC, RV1, DTAPHEPBIP, HIBV, PNC, RV1
Symptoms: Pallor
Clinical narrative: Initial report was received on 19 January 2010 from a health care professional. A six-month-old female patient had received a third dose intramuscular left thigh injection of ACT-HIB, lot number UF672AA (Sanofi Pasteur SA lot number D0551-1), and an intramuscular left thigh injection of PREVNAR (manufacturer Wyeth, lot number D81705) and an oral dose of ROTATEQ (Manufacturer GlaxoSmithKline, lot number A41FA733A) on 18 January 2010 and immediately after receiving these vaccines, the patient's eyes rolled back, she became limp, pale, slightly cyanotic around the mouth, and she stopped crying for approximately 30 seconds to one minute. The patient then began to cry again and was monitored for 30 minutes afterwards. At that time, the patient recovered and was felt to be "ok" and she was then administered a dose of PEDIARIX (lot number AC21B209DA, manufacturer, route and site not reported). According to the reporter, the patient had no concurrent illness, no past medical history, and she had not been taking any concomitant medications. The patient had not experienced any adverse events following prior vaccinations. No additional information was provided at the time of the report. Documents held by sender: None.
Age: 0.53
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, RV1, HIBV, PNC, RV5, HIBV, PNC, RV1, DTAPHEPBIP, HIBV, PNC, RV1
Symptoms: Crying, Cyanosis, Hypotonia, Immediate post-injection reaction, Inappropriate schedule of drug administration
Clinical narrative: Initial report was received on 19 January 2010 from a health care professional. A six-month-old female patient had received a third dose intramuscular left thigh injection of ACT-HIB, lot number UF672AA (Sanofi Pasteur SA lot number D0551-1), and an intramuscular left thigh injection of PREVNAR (manufacturer Wyeth, lot number D81705) and an oral dose of ROTATEQ (Manufacturer GlaxoSmithKline, lot number A41FA733A) on 18 January 2010 and immediately after receiving these vaccines, the patient's eyes rolled back, she became limp, pale, slightly cyanotic around the mouth, and she stopped crying for approximately 30 seconds to one minute. The patient then began to cry again and was monitored for 30 minutes afterwards. At that time, the patient recovered and was felt to be "ok" and she was then administered a dose of PEDIARIX (lot number AC21B209DA, manufacturer, route and site not reported). According to the reporter, the patient had no concurrent illness, no past medical history, and she had not been taking any concomitant medications. The patient had not experienced any adverse events following prior vaccinations. No additional information was provided at the time of the report. Documents held by sender: None.
Age: 0.53
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, RV1, HIBV, PNC, RV5, HIBV, PNC, RV1, DTAPHEPBIP, HIBV, PNC, RV1
Symptoms: Movement disorder, Pallor
Clinical narrative: Initial report was received on 19 January 2010 from a health care professional. A six-month-old female patient had received a third dose intramuscular left thigh injection of ACT-HIB, lot number UF672AA (Sanofi Pasteur SA lot number D0551-1), and an intramuscular left thigh injection of PREVNAR (manufacturer Wyeth, lot number D81705) and an oral dose of ROTATEQ (Manufacturer GlaxoSmithKline, lot number A41FA733A) on 18 January 2010 and immediately after receiving these vaccines, the patient's eyes rolled back, she became limp, pale, slightly cyanotic around the mouth, and she stopped crying for approximately 30 seconds to one minute. The patient then began to cry again and was monitored for 30 minutes afterwards. At that time, the patient recovered and was felt to be "ok" and she was then administered a dose of PEDIARIX (lot number AC21B209DA, manufacturer, route and site not reported). According to the reporter, the patient had no concurrent illness, no past medical history, and she had not been taking any concomitant medications. The patient had not experienced any adverse events following prior vaccinations. No additional information was provided at the time of the report. Documents held by sender: None.
Age: 0.53
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, RV1, HIBV, PNC, RV5, HIBV, PNC, RV1, DTAPHEPBIP, HIBV, PNC, RV1
Symptoms: Cyanosis, Hypotonia, Loss of consciousness, Pallor
Clinical narrative: This case was reported by a physician and described the occurrence of pallor in a 6-month-old female subject who was vaccinated with ROTARIX (Glaxosmithkline), Hib vaccine (Sanofi-Pastuer) and PCV-7 (Wyeth). Previous vaccination included 2 doses of ROTATEQ (Merck) given on unspecified dates. On 18 January 2010 at 16:30 the subject received a dose of ROTARIX (oral), 3rd dose of Hib vaccine (Sanofi-Pasteur) and 3rd dose of PCV-7 (Wyeth). ROTARIX was given as the 3rd rotavirus dose following two previous doses of ROTATEQ vaccine. This was considered to be the wrong vaccine for administration as receiving ROTARIX as the 3rd dose in the ROTATEQ series not recommended. On 18 January 2010, immediately after vaccination with ROTARIX, at an unspecified time after vaccination with HIB Vaccine and pneumococcal vaccines, the subject turned pale, became limp and lay still for 30 seconds to one minute. The baby also turned cyanotic. The physician considered the events were disabling and life threatening. The baby was picked up and held and started to cry. The baby was observed for 30 minutes in the physician's office. At the time of reporting pallor, limp body and loss of movement was resolved (18 January 2010). Outcome of cyanosis was not specified.
Age: 0.53
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, RV1, HIBV, PNC, RV5, HIBV, PNC, RV1, DTAPHEPBIP, HIBV, PNC, RV1
Symptoms: Crying, Cyanosis, Gaze palsy, Hypotonia, Immediate post-injection reaction
Clinical narrative: This case was reported by a physician and described the occurrence of pallor in a 6-month-old female subject who was vaccinated with ROTARIX (Glaxosmithkline), Hib vaccine (Sanofi-Pastuer) and PCV-7 (Wyeth). Previous vaccination included 2 doses of ROTATEQ (Merck) given on unspecified dates. On 18 January 2010 at 16:30 the subject received a dose of ROTARIX (oral), 3rd dose of Hib vaccine (Sanofi-Pasteur) and 3rd dose of PCV-7 (Wyeth). ROTARIX was given as the 3rd rotavirus dose following two previous doses of ROTATEQ vaccine. This was considered to be the wrong vaccine for administration as receiving ROTARIX as the 3rd dose in the ROTATEQ series not recommended. On 18 January 2010, immediately after vaccination with ROTARIX, at an unspecified time after vaccination with HIB Vaccine and pneumococcal vaccines, the subject turned pale, became limp and lay still for 30 seconds to one minute. The baby also turned cyanotic. The physician considered the events were disabling and life threatening. The baby was picked up and held and started to cry. The baby was observed for 30 minutes in the physician's office. At the time of reporting pallor, limp body and loss of movement was resolved (18 January 2010). Outcome of cyanosis was not specified.
Age: 0.53
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, RV1, HIBV, PNC, RV5, HIBV, PNC, RV1, DTAPHEPBIP, HIBV, PNC, RV1
Symptoms: Pallor
Clinical narrative: This case was reported by a physician and described the occurrence of pallor in a 6-month-old female subject who was vaccinated with ROTARIX (Glaxosmithkline), Hib vaccine (Sanofi-Pastuer) and PCV-7 (Wyeth). Previous vaccination included 2 doses of ROTATEQ (Merck) given on unspecified dates. On 18 January 2010 at 16:30 the subject received a dose of ROTARIX (oral), 3rd dose of Hib vaccine (Sanofi-Pasteur) and 3rd dose of PCV-7 (Wyeth). ROTARIX was given as the 3rd rotavirus dose following two previous doses of ROTATEQ vaccine. This was considered to be the wrong vaccine for administration as receiving ROTARIX as the 3rd dose in the ROTATEQ series not recommended. On 18 January 2010, immediately after vaccination with ROTARIX, at an unspecified time after vaccination with HIB Vaccine and pneumococcal vaccines, the subject turned pale, became limp and lay still for 30 seconds to one minute. The baby also turned cyanotic. The physician considered the events were disabling and life threatening. The baby was picked up and held and started to cry. The baby was observed for 30 minutes in the physician's office. At the time of reporting pallor, limp body and loss of movement was resolved (18 January 2010). Outcome of cyanosis was not specified.
Age: 0.53
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, RV1, HIBV, PNC, RV5, HIBV, PNC, RV1, DTAPHEPBIP, HIBV, PNC, RV1
Symptoms: Crying, Cyanosis, Hypotonia, Immediate post-injection reaction, Inappropriate schedule of drug administration
Clinical narrative: This case was reported by a physician and described the occurrence of pallor in a 6-month-old female subject who was vaccinated with ROTARIX (Glaxosmithkline), Hib vaccine (Sanofi-Pastuer) and PCV-7 (Wyeth). Previous vaccination included 2 doses of ROTATEQ (Merck) given on unspecified dates. On 18 January 2010 at 16:30 the subject received a dose of ROTARIX (oral), 3rd dose of Hib vaccine (Sanofi-Pasteur) and 3rd dose of PCV-7 (Wyeth). ROTARIX was given as the 3rd rotavirus dose following two previous doses of ROTATEQ vaccine. This was considered to be the wrong vaccine for administration as receiving ROTARIX as the 3rd dose in the ROTATEQ series not recommended. On 18 January 2010, immediately after vaccination with ROTARIX, at an unspecified time after vaccination with HIB Vaccine and pneumococcal vaccines, the subject turned pale, became limp and lay still for 30 seconds to one minute. The baby also turned cyanotic. The physician considered the events were disabling and life threatening. The baby was picked up and held and started to cry. The baby was observed for 30 minutes in the physician's office. At the time of reporting pallor, limp body and loss of movement was resolved (18 January 2010). Outcome of cyanosis was not specified.
Age: 0.53
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC, RV1, HIBV, PNC, RV5, HIBV, PNC, RV1, DTAPHEPBIP, HIBV, PNC, RV1
Symptoms: Movement disorder, Pallor
Clinical narrative: This case was reported by a physician and described the occurrence of pallor in a 6-month-old female subject who was vaccinated with ROTARIX (Glaxosmithkline), Hib vaccine (Sanofi-Pastuer) and PCV-7 (Wyeth). Previous vaccination included 2 doses of ROTATEQ (Merck) given on unspecified dates. On 18 January 2010 at 16:30 the subject received a dose of ROTARIX (oral), 3rd dose of Hib vaccine (Sanofi-Pasteur) and 3rd dose of PCV-7 (Wyeth). ROTARIX was given as the 3rd rotavirus dose following two previous doses of ROTATEQ vaccine. This was considered to be the wrong vaccine for administration as receiving ROTARIX as the 3rd dose in the ROTATEQ series not recommended. On 18 January 2010, immediately after vaccination with ROTARIX, at an unspecified time after vaccination with HIB Vaccine and pneumococcal vaccines, the subject turned pale, became limp and lay still for 30 seconds to one minute. The baby also turned cyanotic. The physician considered the events were disabling and life threatening. The baby was picked up and held and started to cry. The baby was observed for 30 minutes in the physician's office. At the time of reporting pallor, limp body and loss of movement was resolved (18 January 2010). Outcome of cyanosis was not specified.
Age: 35.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Chills, Headache, Nausea, Pyrexia
Clinical narrative: alternating chills & fever, headache, nausea
Age: 1.03
Sex: M
Vaccine: HEPA, MMR, UNK
Symptoms: Fatigue, Laboratory test, Lymphadenopathy, Pyrexia, Rash
Clinical narrative: Swelling of the paridio gland and surounding glands around the right jaw line to the back of his ear and neck. Fever of 101-102 rash on other cheek. Tiredness for so far 5 days after the doc visit. Very little vomit.
Age: 1.03
Sex: M
Vaccine: HEPA, MMR, UNK
Symptoms: Ultrasound scan, Vomiting
Clinical narrative: Swelling of the paridio gland and surounding glands around the right jaw line to the back of his ear and neck. Fever of 101-102 rash on other cheek. Tiredness for so far 5 days after the doc visit. Very little vomit.
Age: 25.0
Sex: F
Vaccine: MMR
Symptoms: Accidental exposure
Clinical narrative: As an employee, I injected MMR subq to a pt in his R arm. After vaccine injected and needle retracted into syringe 1 splash of MMR retracted out 'n splashed my L eye and eye lash - immediately dabbed w/dry gauze for 4-5 sec.
Age: 11.0
Sex: M
Vaccine: HEPA, MNQ, VARCEL
Symptoms: Erythema, Oedema peripheral
Clinical narrative: 2.5 x 3 in red swelling on the right arm.
Age: 43.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Cardiac arrest, Rash pruritic
Clinical narrative: Initial report received from a consumer on 21 Jan 2010: This patient with no prior history of cardiovascular symptoms was vaccinated with S-OIV Flivirin (Influenza virus vaccine A H1N1) on 19 Jan 2010. The patient reported that after 1 hour of vaccination, her heart stopped. The patient was taken to hospital and stayed overnight. The patient also experienced itchy strawberry rash on arms on 19 Jan 2010 after vaccination. The patient did not experience any cardiovascular symptoms prior to receiving the vaccine. The patient discharged from the hospital. Final outcome of the events was not reported.
Age: 85.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Hallucination
Clinical narrative: Initial report received from a pharmacist on 20 Jan 2010: This patient was vaccinated with S-OIV FLUVIRIN (batch no. unspecified) on 19 Jan 2010. On the same day, the patient experienced hallucination when she went to bed. No hallucinations were experienced unless sleeping. The patient did not recover from the event and final outcome was reported as condition unchanged.
Age: 12.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Body temperature increased, Headache, Vomiting
Clinical narrative: Headache, vomiting, 102 temp. Mother took son to MD 01/15/2010. Back at school 1/18/2010
Age: 13.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Back pain, Hypoaesthesia
Clinical narrative: C/O body numbness on left side and back hurting. Taken to Urgent Care by mother. Child treated with Excedrin (OTC) and Benadryl. Returned to school same day with no further complaints.
Age: 17.0
Sex: F
Vaccine: HPV4
Symptoms: Condition aggravated, Convulsion, Dizziness, Fatigue, Feeling abnormal
Clinical narrative: Patient started feeling dizzy, having headaches. After that patient started complaining of tirness. Patient had these same reation from previous dignious of HPV it made her start having seizure again. After a couple of day getting injection the patient would start feeling bad and then would start having seizures.
Age: 17.0
Sex: F
Vaccine: HPV4
Symptoms: Headache, Vaccine positive rechallenge
Clinical narrative: Patient started feeling dizzy, having headaches. After that patient started complaining of tirness. Patient had these same reation from previous dignious of HPV it made her start having seizure again. After a couple of day getting injection the patient would start feeling bad and then would start having seizures.
Age: 17.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Chills, Heart rate increased, Hyperhidrosis, Muscle twitching, Rash
Clinical narrative: Rash around eyes, spreading to rest of face. Hands and arm purple/red. Muscle twitches in arm and chest, rapid heart rate, chills and sweating.
Age: 17.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Rash erythematous, Skin discolouration
Clinical narrative: Rash around eyes, spreading to rest of face. Hands and arm purple/red. Muscle twitches in arm and chest, rapid heart rate, chills and sweating.
Age: 12.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Pain, Vomiting
Clinical narrative: PATIENT REFERS VOMITING AND PAIN LEFT QUADRANT.
Age: 56.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Arthralgia, Joint swelling
Clinical narrative: Severe pain and swelling of joints: ankles, knees, elbows, wrists, fingers.  Began early morning on 15DEC09 and continued until morning of 16DEC09 when she presented to the hospital.
Age: 75.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Gait disturbance, Hypoaesthesia
Clinical narrative: CLIENT REPORTED NUMBNESS,USING CRUTCHES FOR ASSISTANCE TO WALK.
Age: 52.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Upper respiratory tract congestion
Clinical narrative: upper respiratory symptoms with head congestion, throat and chest congestion
Age: 19.0
Sex: M
Vaccine: SMALL
Symptoms: Rash papular
Clinical narrative: Bilat papules dorsal side of hands.
Age: 64.0
Sex: M
Vaccine: TDAP
Symptoms: Cerebrovascular accident, Fall, Hypoaesthesia, Intensive care, Sensory disturbance
Clinical narrative: Numbness of fingers, ER on 12/16/09, - stroke, numbness "wooden feeling of legs" fell and could not get up. Admitted 12/21/09 for 9 days ICU.
Age: 28.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Abortion spontaneous, Drug exposure during pregnancy, Foetal disorder, Intra-uterine death
Clinical narrative: Initial report received from a consumer on 21 Jan 2010: This patient was vaccinated with H1N1 influenza virus vaccine (manufacturer unknown; batch number 10127805) on 09 Dec 2009. The patient was 8 weeks pregnant when she received the vaccine. On 16 Dec 2009, the patient miscarried at 9 weeks, with subsequent fetal death. A test on the fetus revealed high mercury levels in the tissue. No other symptoms or other occurrence were noted during this time.
Age: 29.0
Sex: F
Vaccine: VARCEL
Symptoms: Blindness, CD4 lymphocytes decreased, Cytomegalovirus antibody negative, Cytomegalovirus antibody positive, Eye pain
Clinical narrative: Patient vaccinated 10/8/2010 at OSH. Patient developed skin rash consistant with chicken pox per report approx. 3 weeks after vaccination. Patient developed eye pain and redness approx. 6-8 weeks after vaccination in both eyes, progressing to blurred vision and some vision loss. Symptoms resolved in left eye, but not right. Patient admitted to faclility with final diagnosis of progressive ocular retinal necrosis. Viral testing showed VZV in intra-ocular fluid by PCR. Patient found to be HIV positive at time of admission with CD4 of 15 and viral load of 315,000.
Age: 29.0
Sex: F
Vaccine: VARCEL
Symptoms: HIV antibody positive, HIV infection, Herpes simplex serology negative, Immunology test, Necrotising retinitis
Clinical narrative: Patient vaccinated 10/8/2010 at OSH. Patient developed skin rash consistant with chicken pox per report approx. 3 weeks after vaccination. Patient developed eye pain and redness approx. 6-8 weeks after vaccination in both eyes, progressing to blurred vision and some vision loss. Symptoms resolved in left eye, but not right. Patient admitted to faclility with final diagnosis of progressive ocular retinal necrosis. Viral testing showed VZV in intra-ocular fluid by PCR. Patient found to be HIV positive at time of admission with CD4 of 15 and viral load of 315,000.
Age: 29.0
Sex: F
Vaccine: VARCEL
Symptoms: Ocular hyperaemia, Polymerase chain reaction, Rash, Varicella post vaccine, Viral DNA test positive
Clinical narrative: Patient vaccinated 10/8/2010 at OSH. Patient developed skin rash consistant with chicken pox per report approx. 3 weeks after vaccination. Patient developed eye pain and redness approx. 6-8 weeks after vaccination in both eyes, progressing to blurred vision and some vision loss. Symptoms resolved in left eye, but not right. Patient admitted to faclility with final diagnosis of progressive ocular retinal necrosis. Viral testing showed VZV in intra-ocular fluid by PCR. Patient found to be HIV positive at time of admission with CD4 of 15 and viral load of 315,000.
Age: 29.0
Sex: F
Vaccine: VARCEL
Symptoms: Viral load increased, Vision blurred
Clinical narrative: Patient vaccinated 10/8/2010 at OSH. Patient developed skin rash consistant with chicken pox per report approx. 3 weeks after vaccination. Patient developed eye pain and redness approx. 6-8 weeks after vaccination in both eyes, progressing to blurred vision and some vision loss. Symptoms resolved in left eye, but not right. Patient admitted to faclility with final diagnosis of progressive ocular retinal necrosis. Viral testing showed VZV in intra-ocular fluid by PCR. Patient found to be HIV positive at time of admission with CD4 of 15 and viral load of 315,000.
Age: 1.06
Sex: M
Vaccine: DTAPIPVHIB, MMR, VARCEL
Symptoms: Rash erythematous
Clinical narrative: Mother noted red rash in genital area. Called MD office. No treatment given since rash was not bothering pt. Not even seen by the MD.
Age: 62.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Erythema, Pruritus, Swelling face
Clinical narrative: Swelling from right eye to below cheekbone to chin.  Slight redness and itching.  Took Benadryl
Age: 21.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Dysphagia
Clinical narrative: Pts mother called and reported the pt was having difficulty swallowing. Pt was at home and was instructed to seek medical attention immediately.
Age: 25.0
Sex: F
Vaccine: HEPA
Symptoms: Pain
Clinical narrative: Generalized achiness from waist down to feet, especially of the joints.
Age: 10.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Asthenia, Convulsion, Fatigue
Clinical narrative: Mother report only!  Mother reports child needing hospitalization for seizures and has suffered weakness and significant fatigue since H1N1 vaccination.
Age: 62.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Urticaria
Clinical narrative: Hives
Age: 6.0
Sex: M
Vaccine: FLUX, FLUX(H1N1)
Symptoms: Attention deficit/hyperactivity disorder, Condition aggravated, Impaired work ability, Staring, Vision blurred
Clinical narrative: Marked increase in inability to focus and complete tasks.  Sensory issues such as jumping up and down, flapping arms and texture issues reappeared after being absent for over 6 months. Blank stares increased also. Second H1N1 shot given 12/14/2009.  High escalation noted in ADHD symptoms.
Age: 36.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Blister, Erythema, Skin discolouration
Clinical narrative: blisters, reddish/purple on front and back of hands; feet; and around and in mouth. RX steriods by PCP
Age: 26.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Cellulitis, Chills, Full blood count abnormal, Injection site pain, Injection site rash
Clinical narrative: Post vaccinations on 1/14/10, patient developed fever of 102, chills and pain in left deltoid and arm. Was seen on 1/15 at which time a rash had developed on her upper left arm. She was admitted to hospital on 1/17/10 for cellulitis. A doppler study revealed a clot in the anterior brachial vein. She was placed on IV antibiotics and started on LEVONOX.
Age: 26.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Pain in extremity, Pyrexia, Thrombosis, White blood cell count increased
Clinical narrative: Post vaccinations on 1/14/10, patient developed fever of 102, chills and pain in left deltoid and arm. Was seen on 1/15 at which time a rash had developed on her upper left arm. She was admitted to hospital on 1/17/10 for cellulitis. A doppler study revealed a clot in the anterior brachial vein. She was placed on IV antibiotics and started on LEVONOX.
Age: 57.0
Sex: F
Vaccine: ANTH
Symptoms: Biopsy, Mouth ulceration, Oral disorder, Pemphigus
Clinical narrative: Shortly after vaccination pt began to experience recurrent and worsening mouth ulceration that was diagnosed by biopsy in Oct 09 as Pemphigus vulgaris (PV). Symptoms: Oral lesions.
Age: 32.0
Sex: F
Vaccine: FLUN3
Symptoms: Convulsion, Dizziness, Loss of consciousness
Clinical narrative: Patient received FluMist. While in observation, patient became lightheaded then became unconscious and had seizure like activity lasting approx. 10 secs. Patient lowered to ground level with feet elevated. Vital signs taken. 911 called. Patient transported to Emergency Room by EMS. After seizure activity, patient was alert and oriented x 3; reported being evaluated for symptoms by a neurologist.
Age: 55.0
Sex: F
Vaccine: FLU(H1N1), PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: 12-24 hrs after vaccine given, pt. reports L deltoid very red, swollen and painful, later noticed rash down arm to elbow-resolving by 12/16/09.
Age: 8.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site vesicles
Clinical narrative: Redness, swelling measuring 15x 11.5cm with central area of multiple small blisters 5x3 in surrounding vaccines site.
Age: 4.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: L thigh at site of vaccine with red mildly swollen, warm to touch, mild tenderness, a little hard to touch.
Age: 65.0
Sex: F
Vaccine: FLUN(H1N1)
Symptoms: Wrong drug administered
Clinical narrative: Patient was given MedImmune Flu A h1N1 in nasal spray form which is not approved for person's over age 49 years.
Age: 4.0
Sex: F
Vaccine: DTAPHEPBIP, HEPA, MMR, VARCEL
Symptoms: Injection site reaction
Clinical narrative: localized reaction 9 cm R thigh at injection site that received MMR and VARICELLA
Age: 41.0
Sex: U
Vaccine: FLU(H1N1)
Symptoms: Dyspnoea, Injection site erythema, Injection site swelling
Clinical narrative: Developed redness/swelling at injection site with SOB, seen in ER.
Age: 24.0
Sex: F
Vaccine: FLUN(H1N1)
Symptoms: Drug exposure during pregnancy
Clinical narrative: None stated.
Age: 13.0
Sex: F
Vaccine: TDAP
Symptoms: Dizziness, Headache, Nausea, Pain, Pyrexia
Clinical narrative: nausea, dizziness, headache. body aches, fever of 101.9.
Age: 0.34
Sex: M
Vaccine: DTAPIPVHIB, PNC, RV1
Symptoms: Rash
Clinical narrative: Fine rash, thighs, chest - skin colored. Same reaction happened to mom's sister's children (cousins)
Age: 16.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Chills, Dizziness, Fatigue, Flank pain, Headache
Clinical narrative: 20 min after receiving injection C/o dizzy nausea MA, R flank pain intermittent scale 1-10 3 chills, tired BP 120/60, 100/50 P 100x2, R 22x2, T 98.9. Called  home doctor where he is living. Advised they will pick up student + take him to MD.
Age: 16.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Nausea
Clinical narrative: 20 min after receiving injection C/o dizzy nausea MA, R flank pain intermittent scale 1-10 3 chills, tired BP 120/60, 100/50 P 100x2, R 22x2, T 98.9. Called  home doctor where he is living. Advised they will pick up student + take him to MD.
Age: 11.0
Sex: F
Vaccine: VARZOS
Symptoms: Wrong drug administered
Clinical narrative: Varicella was ordered. Zostavax was given by mistake. No reaction by patient.
Age: 52.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Injection site pain
Clinical narrative: Pt says she experienced severe soreness at injection site which is worsening.
Age: 19.0
Sex: F
Vaccine: FLU(H1N1), PNC
Symptoms: Erythema, Skin reaction
Clinical narrative: 20 cm diameter, slightly raised erythema over left bicep. -Localized reaction afebrile. No shortness of breath.
Age: 76.0
Sex: F
Vaccine: FLU(H1N1), PPV
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site warmth
Clinical narrative: Client came to Health Agency on 1/21/10. Reports had PNEUMOVAX in R arm and H1N1 shot in L arm on 1/20/10. Reports extreme pain in R arm post injection. R bicep area contains 3" x 7" red indurated area. Area warm to touch. Reports redness began 1/20/10 and became worse 1/21/10-seen at clinic on 1/22/10. MD stated was vaccine-related reaction. MD advised to apply heat to area.
Age: 38.0
Sex: F
Vaccine: TDAP
Symptoms: Hypersensitivity, Hypoaesthesia, Oedema peripheral, Pain, Pain in extremity
Clinical narrative: Received Tdap left deltoid 1-2--10 at approximately 4:45pm. At approx 6-6:30 developed achy pain left arm. 1-21-10 woke up with numbness and pain left arm with movement. Pain radiates from arm down to hand, finger numb and hypersensitive. No previous vaccine reaction. Placed on Neurotin and Motrin with a neurology referral. RTC 1-22-10 Continued to have arm left pain, Neurotin allowed patient to sleep, left arm swelling using sling, arm not as cold.
Age: 38.0
Sex: F
Vaccine: TDAP
Symptoms: Peripheral coldness
Clinical narrative: Received Tdap left deltoid 1-2--10 at approximately 4:45pm. At approx 6-6:30 developed achy pain left arm. 1-21-10 woke up with numbness and pain left arm with movement. Pain radiates from arm down to hand, finger numb and hypersensitive. No previous vaccine reaction. Placed on Neurotin and Motrin with a neurology referral. RTC 1-22-10 Continued to have arm left pain, Neurotin allowed patient to sleep, left arm swelling using sling, arm not as cold.
Age: 58.0
Sex: F
Vaccine: PPV
Symptoms: Cellulitis, Convulsion, Erythema, Oedema peripheral, Skin warm
Clinical narrative: 1/21/2010 , 2100 Left arm swollen, red, warm to touch-per nurses notes. 1/22/10 RN reports area is firm, red, warm to touch. Primaxin 500mg N every 6 hours for treatment (possible Cellulitis).
Age: 58.0
Sex: F
Vaccine: PPV
Symptoms: White blood cell count increased
Clinical narrative: 1/21/2010 , 2100 Left arm swollen, red, warm to touch-per nurses notes. 1/22/10 RN reports area is firm, red, warm to touch. Primaxin 500mg N every 6 hours for treatment (possible Cellulitis).
Age: 23.0
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Asthenia, Blood test, Chills, Decreased appetite, Fall
Clinical narrative: 2 hours after receiving the seasonal flu shot, the subject started feeling weak, tired, and nauseous. She then began shivering vigorously and fell, but was conscious throughout. This lasted for 3 hrs. She was taken to the ER where she had an episode of vomiting, chills, and  fever of 101 deg. She experienced malaise, fatigue, decrease appetite, numbness/tingling of limbs, muscle pain, difficulty walking, and difficulty moving arms/legs. Blood tests were non-conclusive. She received IV fluids and was discharged from the ER the same evening. The subject experienced continued weakness for 1 week.
Age: 23.0
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Fatigue, Gait disturbance, Hypoaesthesia, Malaise, Mobility decreased
Clinical narrative: 2 hours after receiving the seasonal flu shot, the subject started feeling weak, tired, and nauseous. She then began shivering vigorously and fell, but was conscious throughout. This lasted for 3 hrs. She was taken to the ER where she had an episode of vomiting, chills, and  fever of 101 deg. She experienced malaise, fatigue, decrease appetite, numbness/tingling of limbs, muscle pain, difficulty walking, and difficulty moving arms/legs. Blood tests were non-conclusive. She received IV fluids and was discharged from the ER the same evening. The subject experienced continued weakness for 1 week.
Age: 23.0
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Myalgia, Nausea, Paraesthesia, Pyrexia, Vomiting
Clinical narrative: 2 hours after receiving the seasonal flu shot, the subject started feeling weak, tired, and nauseous. She then began shivering vigorously and fell, but was conscious throughout. This lasted for 3 hrs. She was taken to the ER where she had an episode of vomiting, chills, and  fever of 101 deg. She experienced malaise, fatigue, decrease appetite, numbness/tingling of limbs, muscle pain, difficulty walking, and difficulty moving arms/legs. Blood tests were non-conclusive. She received IV fluids and was discharged from the ER the same evening. The subject experienced continued weakness for 1 week.
Age: 23.0
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Altered state of consciousness, Asthenia, Blood test, Chills, Fatigue
Clinical narrative: 2 hours after receiving the seasonal flu shot, the subject started feeling weak, tired, and nauseous. She then began shivering vigorously and fell, but was conscious throughout. This lasted for 3 hrs. She was taken to the ER where she had an episode of vomiting, chills, and  fever of 101 deg. She experienced malaise, fatigue, decrease appetite, numbness/tingling of limbs, muscle pain, difficulty walking, and difficulty moving arms/legs. Blood tests were non-conclusive. She received IV fluids and was discharged from the ER the same evening. The subject experienced continued weakness for 1 week.
Age: 23.0
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Gait disturbance, Hypokinesia, Immediate post-injection reaction, Malaise, Nausea
Clinical narrative: 2 hours after receiving the seasonal flu shot, the subject started feeling weak, tired, and nauseous. She then began shivering vigorously and fell, but was conscious throughout. This lasted for 3 hrs. She was taken to the ER where she had an episode of vomiting, chills, and  fever of 101 deg. She experienced malaise, fatigue, decrease appetite, numbness/tingling of limbs, muscle pain, difficulty walking, and difficulty moving arms/legs. Blood tests were non-conclusive. She received IV fluids and was discharged from the ER the same evening. The subject experienced continued weakness for 1 week.
Age: 23.0
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Pyrexia, Vomiting
Clinical narrative: 2 hours after receiving the seasonal flu shot, the subject started feeling weak, tired, and nauseous. She then began shivering vigorously and fell, but was conscious throughout. This lasted for 3 hrs. She was taken to the ER where she had an episode of vomiting, chills, and  fever of 101 deg. She experienced malaise, fatigue, decrease appetite, numbness/tingling of limbs, muscle pain, difficulty walking, and difficulty moving arms/legs. Blood tests were non-conclusive. She received IV fluids and was discharged from the ER the same evening. The subject experienced continued weakness for 1 week.
Age: 23.0
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Asthenia, Blood test, Chills, Decreased appetite, Fall
Clinical narrative: Two hours after getting the seasonal flu vaccine she started feeling weak and had nausea. There after she started shivering vigorously and this continued for 3 hours, she had difficulty moving arms or limbs and difficulty walking. She was conscious all throughout the episode. She was taken to the emergency room where she had an episode of vomiting and ran a fever of 101 degrees. She also reported chills, malaise and fatigue. Some blood tests were done and she received fluids. She was discharged from the ER by the evening. The weakness continued for a week.
Age: 23.0
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Fatigue, Gait disturbance, Hypoaesthesia, Malaise, Mobility decreased
Clinical narrative: Two hours after getting the seasonal flu vaccine she started feeling weak and had nausea. There after she started shivering vigorously and this continued for 3 hours, she had difficulty moving arms or limbs and difficulty walking. She was conscious all throughout the episode. She was taken to the emergency room where she had an episode of vomiting and ran a fever of 101 degrees. She also reported chills, malaise and fatigue. Some blood tests were done and she received fluids. She was discharged from the ER by the evening. The weakness continued for a week.
Age: 23.0
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Myalgia, Nausea, Paraesthesia, Pyrexia, Vomiting
Clinical narrative: Two hours after getting the seasonal flu vaccine she started feeling weak and had nausea. There after she started shivering vigorously and this continued for 3 hours, she had difficulty moving arms or limbs and difficulty walking. She was conscious all throughout the episode. She was taken to the emergency room where she had an episode of vomiting and ran a fever of 101 degrees. She also reported chills, malaise and fatigue. Some blood tests were done and she received fluids. She was discharged from the ER by the evening. The weakness continued for a week.
Age: 23.0
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Altered state of consciousness, Asthenia, Blood test, Chills, Fatigue
Clinical narrative: Two hours after getting the seasonal flu vaccine she started feeling weak and had nausea. There after she started shivering vigorously and this continued for 3 hours, she had difficulty moving arms or limbs and difficulty walking. She was conscious all throughout the episode. She was taken to the emergency room where she had an episode of vomiting and ran a fever of 101 degrees. She also reported chills, malaise and fatigue. Some blood tests were done and she received fluids. She was discharged from the ER by the evening. The weakness continued for a week.
Age: 23.0
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Gait disturbance, Hypokinesia, Immediate post-injection reaction, Malaise, Nausea
Clinical narrative: Two hours after getting the seasonal flu vaccine she started feeling weak and had nausea. There after she started shivering vigorously and this continued for 3 hours, she had difficulty moving arms or limbs and difficulty walking. She was conscious all throughout the episode. She was taken to the emergency room where she had an episode of vomiting and ran a fever of 101 degrees. She also reported chills, malaise and fatigue. Some blood tests were done and she received fluids. She was discharged from the ER by the evening. The weakness continued for a week.
Age: 23.0
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Pyrexia, Vomiting
Clinical narrative: Two hours after getting the seasonal flu vaccine she started feeling weak and had nausea. There after she started shivering vigorously and this continued for 3 hours, she had difficulty moving arms or limbs and difficulty walking. She was conscious all throughout the episode. She was taken to the emergency room where she had an episode of vomiting and ran a fever of 101 degrees. She also reported chills, malaise and fatigue. Some blood tests were done and she received fluids. She was discharged from the ER by the evening. The weakness continued for a week.